Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02324413Phase 3Completed
Phase 3, randomised, double-blind trial of clonidine. Primary endpoint: Post-Hospitalization Behavior Questionnaire at 7 days. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02324413.